NCT02868645View on ClinicalTrials.gov

Interest of Serum Periostin Dosage in Patients With Bone Fibrous Dysplasia

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

May 25, 2016

Primary Completion Date

April 10, 2018

Study Completion Date

April 10, 2018

Conditions
Bone Fibrous Dysplasia
Interventions
BIOLOGICAL

Blood sampling

Patients with bone fibrous dysplasia will have blood sampling to assess periostin rate in serum

Trial Locations (1)

69437

Service de rhumatologie Pavillon F - Hôpital Edouard Herriot, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT02868645 - Interest of Serum Periostin Dosage in Patients With Bone Fibrous Dysplasia | Biotech Hunter | Biotech Hunter